Page 94 - Clinical Development News Today

Strengthened Clinical and Regulatory Leadership Team with Key AppointmentsStart-up Activities for the Global Phase 3 Trial Ongoing with Release of Drug Product Manufactured with Commercial Process and First Patient Expected to be Dosed in 2H 2023BOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinic...

A new treatment option for adults with metastatic colorectal cancer (mCRC) could ‘change the landscape’ for those with the disease.

OSP was fortunate enough to have an interesting discussion with Stephen Corson, who is a statistics manager at Phastar, a specialist biometrics CRO headquartered in the UK.

Biocon Biologics has made several key leadership appointments which will play an important role in transforming the organization and realizing the Company’s ambition of building a global biosimilars leader. Rhonda Duffy has been appointed Chief Operating Officer (COO) and will lead Manufacturing, Quality and Supply Chain Management. She brings over 30-years of experience in the

SAN DIEGO, Aug. 07, 2023 -- Viracta Therapeutics, Inc. , a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients...

The first oral pill in the United States specifically for postpartum depression, a serious mental illness, has been approved by the US Food and Drug Administration (FDA).

At-risk families of patients diagnosed with motor neurone disease (MND), better known in the US as amyotrophic lateral sclerosis (ALS) will now have access to genetic sequencing thanks to a financial award from Innovate UK.

The US Food and Drug Administration (FDA) has today (July 31) given clearance via its 510(k) process to one of the artificial intelligence solutions cleared for colonoscopy.

Based on the OI percentage, 64 stocks were on the short-covering list. These included Bharti Airtel, Axis Bank, Laurus Labs, Torrent Pharmaceuticals, and Jubilant Foodworks. A decrease in OI along with a price increase is an indication of short-covering.

In addition to key leadership appointments, BBL has also on-boarded global leadership talent across several functions including Manufacturing Science and Technology, Clinical Development, Finance, HR, Legal and Compliance